Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00108_DB04572> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00108_DB04572 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00108_DB04572 label "DDI between Natalizumab and Thiotepa - The immunosuppressant, Thiotepa, may increase the adverse effects of Natalizumab. Increased risk of Progressive Multifocal Leukoencephalopathy (PML) and other infections. Concurrent therapy should be avoided. [drugbank_resource:DB00108_DB04572]" assertion.
- drugbank_resource:DB00108_DB04572 identifier "drugbank_resource:DB00108_DB04572" assertion.
- drugbank_resource:DB00108_DB04572 title "DDI between Natalizumab and Thiotepa - The immunosuppressant, Thiotepa, may increase the adverse effects of Natalizumab. Increased risk of Progressive Multifocal Leukoencephalopathy (PML) and other infections. Concurrent therapy should be avoided." assertion.